Ortho Clinical Diagnostics Holdings plc – NASDAQ:OCDX

Add to watchlist

$17.63

Market closed

Open in 2 days

-1.12%

quarter

-14.79%

year

Market Cap	N/A
Enterprise value	6.15B

P/E	-42.27
EV/Sales	3.02
EV/EBITDA	14.14
Price/Sales	2.05
Price/Book	9.43
PEG ratio	-0.43
EPS	-0.15

Revenue	2.02B
EBITDA	462.9M
Income	-29.6M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	-0.02%
Oper. margin	8.03%
Gross margin	50.49%
EBIT margin	8.03%
EBITDA margin	22.89%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX): Profit margin
Apr 2021	506.8M	-39.1M	-7.72%
Jul 2021	492.5M	-20M	-4.06%
Oct 2021	522.5M	14.7M	2.81%
Apr 2022	500.1M	14.8M	2.96%

Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX): Earnings per share (EPS)
2021-08-04	0.11	0.12
2021-11-03	0.14	0.19
2022-02-16	0.13	0.17
2022-05-04	0.21	0.22

Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX): Debt to assets
Apr 2021	3392500000	3.01B	88.9%
Jul 2021	3304200000	2.92B	88.63%
Oct 2021	3309900000	2.91B	88.01%
Apr 2022	3316400000	2.87B	86.63%

Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX): Cash Flow
Apr 2021	-9.9M	-10.7M	41.1M
Jul 2021	132.7M	6.4M	-91.3M
Oct 2021	65.4M	-7.4M	-11.7M
Apr 2022	-4M	-27.2M	2.1M

Ortho Clinical Diagnostics Holdings alternative data

Ortho Clinical Diagnostics Holdings
Employees

Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX): Employee count
Aug 2023	4,800
Sep 2023	4,800
Oct 2023	4,800
Nov 2023	4,800
Dec 2023	4,800
Jan 2024	4,800
Feb 2024	4,800
Mar 2024	4,800
Apr 2024	4,800
May 2024	4,800
Jun 2024	4,800
Jul 2024	4,800

Ortho Clinical Diagnostics Holdings
Insider Trading

Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX): Insider trades (number of shares)
Period	Buy	Sel
Aug 2021	0	782757
Sep 2021	0	25300000
Oct 2021	0	75464
Jan 2022	0	230000
Apr 2022	0	88043

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	4 Apr 2022	SCHLESINGER MICHAEL A. officer: EVP, GC ..	Stock Option	88,043	$6.28	$552,910
Sale	4 Apr 2022	SCHLESINGER MICHAEL A. officer: EVP, GC ..	Ordinary Shares, $0.00001 par value	88,043	$18.77	$1,652,215
Option	4 Apr 2022	SCHLESINGER MICHAEL A. officer: EVP, GC ..	Ordinary Shares, $0.00001 par value	88,043	$6.28	$552,910
Option	3 Jan 2022	SCHLESINGER MICHAEL A. officer: EVP, GC ..	Stock Option	130,000	$6.28	$816,400
Sale	3 Jan 2022	SCHLESINGER MICHAEL A. officer: EVP, GC ..	Ordinary Shares, $0.00001 par value	130,000	$21.09	$2,741,570
Option	3 Jan 2022	SCHLESINGER MICHAEL A. officer: EVP, GC ..	Ordinary Shares, $0.00001 par value	130,000	$6.28	$816,400
Option	3 Jan 2022	SMITH CHRISTOPHER M director, officer..	Stock Option	100,000	$12.56	$1,256,000
Sale	3 Jan 2022	SMITH CHRISTOPHER M director, officer..	Ordinary Shares, $0.00001 par value	100,000	$21.1	$2,109,800
Option	3 Jan 2022	SMITH CHRISTOPHER M director, officer..	Ordinary Shares, $0.00001 par value	100,000	$12.56	$1,256,000
Option	15 Oct 2021	SCHLESINGER MICHAEL A. officer: EVP, GC ..	Stock Option	75,464	$6.28	$473,914

OCDX insider trading transactions

Ortho Clinical Diagnostics Holdings
Earnings Call Transcripts

Quarter	Transcript
Q1 2022 7 May 2022	Q1 2022 Earnings Call Transcript
Q4 2021 16 Feb 2022	Q4 2021 Earnings Call Transcript
Q3 2021 7 Nov 2021	Q3 2021 Earnings Call Transcript
Q2 2021 7 Aug 2021	Q2 2021 Earnings Call Transcript

OCDX earnings call transcripts

Ortho Clinical Diagnostics Holdings
Executives

Insider	Age	Compensation
Mr. Christopher Michael Smith (1963) Chairman & Chief Executive Officer	62	$2,850,000
Mr. Michael A. Schlesinger (1959) Executive Vice President, Gen. Counsel & Sec.	66	$879,130
Dr. Chockalingam Palaniappan Ph.D. (1965) Chief Innovation Officer	60	$826,630
Mr. Michael S. Iskra (1970) Executive Vice President of Commercial Excellence & Strategy	55	$760,230
Mr. Joseph M. Busky CPA (1968) Chief Financial Officer	57	$607,060

Ortho Clinical Diagnostics Holdings
Latest News

Saturday, 7 May 2022
18:23	Ortho Clinical Diagnostics Holdings PLC (OCDX) CEO Chris Smith on Q1 2022 Results - Earnings Call Transcript	Seeking Alpha
Thursday, 28 April 2022
13:32	Why Ortho Clinical (OCDX) Could Beat Earnings Estimates Again	Zacks Investment Research
Friday, 1 April 2022
13:23	OCDX vs. DOCS: Which Stock Is the Better Value Option?	Zacks Investment Research
Thursday, 24 March 2022
13:33	Ortho Clinical (OCDX) Upgraded to Strong Buy: Here's What You Should Know	Zacks Investment Research
09:47	New Strong Buy Stocks for March 24th	Zacks Investment Research
Tuesday, 15 March 2022
12:48	OCDX vs. PGNY: Which Stock Should Value Investors Buy Now?	Zacks Investment Research
Friday, 25 February 2022
13:50	Will Ortho Clinical (OCDX) Gain on Rising Earnings Estimates?	Zacks Investment Research
Friday, 18 February 2022
10:05	New Strong Buy Stocks for February 18th	Zacks Investment Research
10:05	Best Value Stocks to Buy for February 18th	Zacks Investment Research
Wednesday, 16 February 2022
22:28	Ortho Clinical Diagnostics Holdings PLC (OCDX) CEO Christopher Smith on Q4 2021 Results - Earnings Call Transcript	Seeking Alpha
19:19	Ortho Clinical Diagnostics (OCDX) Tops Q4 Earnings and Revenue Estimates	Zacks Investment Research
Thursday, 23 December 2021
12:18	OCDX Stock Alert: 9 Things to Know About the Quidel Deal Sending Ortho Clinical Higher	InvestorPlace
10:28	Medical Equipment Stock Surges on Buyout Buzz	Schaeffers Research
09:15	JD.com Is Falling, But an M&A Bid Is Lifting This Small Nasdaq Stock Thursday	The Motley Fool
08:16	Quidel To Buy Ortho Clinical Diagnostics For $24.68/Share: Highlights	Benzinga
07:11	Quidel buying Ortho Clinical Diagnostics in $6 billion deal	Market Watch
Sunday, 7 November 2021
15:45	Ortho Clinical Diagnostics Holdings plc (OCDX) CEO Chris Smith on Q3 2021 Results - Earnings Call Transcript	Seeking Alpha
Tuesday, 12 October 2021
16:15	Ortho Clinical Diagnostics to Report Third Quarter 2021 Results on November 3, 2021	GlobeNewsWire
Tuesday, 14 September 2021
16:15	Ortho Clinical Diagnostics Announces Closing of Secondary Offering of Ordinary Shares and Full Exercise of Underwriters' Option to Purchase Additional Ordinary Shares	GlobeNewsWire
Thursday, 9 September 2021
19:15	Ortho Clinical Diagnostics Announces Pricing of Secondary Offering of Ordinary Shares	GlobeNewsWire
Tuesday, 7 September 2021
16:21	Ortho Clinical Diagnostics Announces Secondary Offering of Ordinary Shares	GlobeNewsWire
Friday, 3 September 2021
09:00	Ortho Clinical Diagnostics to Participate in September Investor Conferences	GlobeNewsWire

Ideas & Opinions

Seeking Alpha 23 May 2022

Merger Arbitrage Mondays: Carlyle To Acquire Defense Contractor ManTech
Seeking Alpha 11 Apr 2022

Quidel: A Pure-Play Point-Of-Care Solution Worth A Look
Seeking Alpha 18 Jan 2022

Quidel: Expensive But Accretive Acquisition

Frequently Asked Questions (FAQ)

What's the price of Ortho Clinical Diagnostics Holdings stock today?

One share of Ortho Clinical Diagnostics Holdings stock can currently be purchased for approximately $17.63.
When is Ortho Clinical Diagnostics Holdings's next earnings date?

Unfortunately, Ortho Clinical Diagnostics Holdings's (OCDX) next earnings date is currently unknown.
Does Ortho Clinical Diagnostics Holdings pay dividends?

No, Ortho Clinical Diagnostics Holdings does not pay dividends.
What is Ortho Clinical Diagnostics Holdings's stock symbol?

Ortho Clinical Diagnostics Holdings plc is traded on the NASDAQ under the ticker symbol "OCDX".
What is Ortho Clinical Diagnostics Holdings's primary industry?

Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
How do i buy shares of Ortho Clinical Diagnostics Holdings?

Shares of Ortho Clinical Diagnostics Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Ortho Clinical Diagnostics Holdings's key executives?
Ortho Clinical Diagnostics Holdings's management team includes the following people:
- Mr. Christopher Michael Smith Chairman & Chief Executive Officer(age: 62, pay: $2,850,000)
- Mr. Michael A. Schlesinger Executive Vice President, Gen. Counsel & Sec.(age: 66, pay: $879,130)
- Dr. Chockalingam Palaniappan Ph.D. Chief Innovation Officer(age: 60, pay: $826,630)
- Mr. Michael S. Iskra Executive Vice President of Commercial Excellence & Strategy(age: 55, pay: $760,230)
- Mr. Joseph M. Busky CPA Chief Financial Officer(age: 57, pay: $607,060)
How many employees does Ortho Clinical Diagnostics Holdings have?

As Jul 2024, Ortho Clinical Diagnostics Holdings employs 4,800 workers.
When Ortho Clinical Diagnostics Holdings went public?

Ortho Clinical Diagnostics Holdings plc is publicly traded company for more then 4 years since IPO on 28 Jan 2021.
What is Ortho Clinical Diagnostics Holdings's official website?

The official website for Ortho Clinical Diagnostics Holdings is orthoclinicaldiagnostics.com.
Where are Ortho Clinical Diagnostics Holdings's headquarters?

Ortho Clinical Diagnostics Holdings is headquartered at 1001 Route 202, Raritan, NJ.
How can i contact Ortho Clinical Diagnostics Holdings?

Ortho Clinical Diagnostics Holdings's mailing address is 1001 Route 202, Raritan, NJ and company can be reached via phone at +90 82188000.

Ortho Clinical Diagnostics Holdings plc

orthoclinicaldiagnostics.com

Exchange:

NASDAQ

Full time employees:

4,800

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

Ortho Clinical Diagnostics Holdings plc provides in-vitro diagnostics solutions to the clinical laboratory and transfusion medicine communities worldwide. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company is also involved in the provision of contract manufacturing and orthocare services. Its products are used in hospitals, laboratories, clinics, blood banks, and donor centers. Ortho Clinical Diagnostics Holdings plc was founded in 1939 and is headquartered in Raritan, New Jersey.

+90 82188000

1001 Route 202
Raritan, NJ 08869

CIK: 0001828443
ISIN: GB00BMDNH979
: